| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |